Beijing Tiantan Biological Products Co., Ltd. announced that According to preliminary statistics of its financial department, the Company predicts that its net profit belonging to shareholders of the listed company in the 2019 will be about RMB 614,230,000, with an increase of about 21% compared with the same period of the year before. The net profit belonging to shareholders of the listed company in 2019 after excluding extraordinary profit and loss will be about RMB 612,760,000, with an increase of about 21% compared with the same period of the year before.